Elanco Animal Health Inc (symbol: ELAN) is the issuer of record for a Form 4 filing submitted to the SEC. Modi Rajeev A. reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health Inc (ELAN) reported that Executive Vice President U.S. Pet Health and Global Digital Transformation Rajeev A. Modi received an equity-based award of 65.8756 Deferred Stock Units on September 18, 2026. Each unit represents the right to receive one share of common stock or the cash equivalent and is scheduled to settle in cash or shares after employment ends or in a specified future year under the company’s Executive Deferral and Stock Match Plan. Following this award, Modi holds a total of 9,896.4707 Deferred Stock Units directly.
Elanco Animal Health Inc (symbol: ELAN) is the issuer of record for a Form 4 filing submitted to the SEC. VanHimbergen Robert M reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health Inc (ELAN) reported that EVP and CFO Robert M. VanHimbergen received a grant of 8.7877 Deferred Stock Units on September 18, 2026. Each unit represents the right to receive one share of common stock or the cash equivalent, generally settling after employment termination or in a specified future year. Following this award, he holds 158.6535 Deferred Stock Units directly.
Elanco Animal Health Inc (symbol: ELAN) is the issuer of record for a Form 4 filing submitted to the SEC. VanHimbergen Robert M reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health Inc (ELAN) reported that its EVP and CFO, Robert M. VanHimbergen, received a grant of 8.0416 Deferred Stock Units on September 4, 2026. Each unit represents the right to receive one share of common stock or the cash equivalent, bringing his directly held deferred stock units to 149.8658.
Elanco Animal Health Inc (symbol: ELAN) is the issuer of record for a Form 4 filing submitted to the SEC. Modi Rajeev A. reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health Inc (ELAN) reported that executive Rajeev A. Modi, Executive Vice President U.S. Pet Health and Global Digital Transformation, received a grant of 60.2829 Deferred Stock Units on September 4, 2026. Following this award, he holds 9,830.5951 Deferred Stock Units directly.
Each Deferred Stock Unit represents the right to receive one share of Elanco common stock or the cash equivalent, settling in cash or shares after termination of employment or in a specified future year under the Executive Deferral and Stock Match Plan.
Elanco Animal Health Inc (symbol: ELAN) is the issuer of record for a Form 4 filing submitted to the SEC. Simmons Jeffrey N reported acquisition or exercise transactions in this Form 4 filing.
Elanco Animal Health Inc (ELAN) reported that President and CEO Jeffrey N. Simmons received a grant of 115.3849 Deferred Stock Units on September 4, 2026. Each unit represents the right to receive one share of common stock or the cash equivalent and will settle after employment ends or in a specified future year under the company’s Executive Deferral and Stock Match Plan. Following this award, Simmons holds 25,245.5086 Deferred Stock Units directly.
Elanco Animal Health Inc (ELAN) reported that Executive Vice President U.S. Pet Health and Global Digital Transformation Rajeev A. Modi acquired 61.6158 Deferred Stock Units on 2026-08-21 as a grant or award. Each unit corresponds to one share of common stock or the cash equivalent and will settle in cash or shares after employment ends or in a specified future year under the Executive Deferral and Stock Match Plan. Following this award, Modi holds a total of 9,770.3122 Deferred Stock Units directly.
Elanco Animal Health Inc (ELAN) reported that EVP and CFO Robert M. VanHimbergen acquired 8.2194 Deferred Stock Units on 2026-08-21 as a grant/award. Each unit corresponds to one share of common stock or the cash equivalent and will settle in cash or shares after employment ends or in a specified future year. Following this award, he directly holds 141.8242 Deferred Stock Units.
Elanco Animal Health Inc (symbol: ELAN) is the issuer of record for a Form 4 filing submitted to the SEC.
Elanco Animal Health Inc (ELAN) director Lawrence Erik Kurzius reported an open-market purchase of 40,000 shares of common stock on August 20, 2026 at a weighted average price of $23.398 per share, with individual trades ranging from $23.385 to $23.40. Following these purchases, his reported direct holdings increased to 188,647 shares of Elanco common stock.
Elanco Animal Health Inc (ELAN) reported that officer Shiv O'Neill, General Counsel and Corporate Secretary, purchased 3,998 shares of common stock on 2026-08-18 at $23.58 per share in an open-market or private transaction. After this trade, O'Neill directly holds 87,832 shares of Elanco common stock. The transaction was not made pursuant to a Rule 10b5-1 trading plan.